![Juan Jaen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 37 M $ al 30/06/2026
Dr. Juan C.
Jaen is a President at Arcus Biosciences, Inc. He is on the Board of Directors at Bella Charitable Foundation, Breakpoint Therapeutics GmbH, Hexagon Bio, Inc., R2M Pharma, Inc. and Shasqi, Inc. Dr. Jaen was previously employed as a President, Head-Research & Development by Flexus Biosciences, Inc., a President, Head-Research & Development by FLX Bio, Inc., a Chief Scientific Officer & SVP-Drug Discovery by ChemoCentryx, Inc., a VP-Chemistry & Director-Medicinal Chemistry by Tularik, Inc., a Vice President-Chemistry by Amgen, Inc., a Chemistry Director by Parke-Davis & Co. Ltd., and a Chemistry Director by Warner-Lambert Co. He also served on the board at PACT Pharma, Inc. He received his undergraduate degree from Universidad Complutense de Madrid and a doctorate degree from the University of Michigan.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARCUS BIOSCIENCES, INC. 0,95 % | 10/07/2026 | 1.200.531 ( 0,95 % ) | 37 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Fundador | 01/01/2015 |
R2M Pharma, Inc.
 R2M Pharma, Inc. BiotechnologyHealth Technology Develops, discovers and manufactures pharmaceutical products | Director/Miembro de la Junta | - |
Bella Charitable Foundation
 Bella Charitable Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a grant making charity | Director/Miembro de la Junta | 01/06/2015 |
Breakpoint Therapeutics GmbH
 Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops anti-cancer and oncology drugs | Director/Miembro de la Junta | - |
Hexagon Bio, Inc.
 Hexagon Bio, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company that develops microbial genomes into novel therapeutics for oncology and infectious diseases | Director/Miembro de la Junta | - |
Shasqi, Inc.
 Shasqi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Flexus Biosciences, Inc.
 Flexus Biosciences, Inc. BiotechnologyHealth Technology Provides cancer therapeutics through innovative apps | Fundador | 01/04/2015 |
| RAPT THERAPEUTICS, INC. | Presidente | 01/04/2015 |
| CHEMOCENTRYX, INC. | Director Técnico/Científico/I+D | 01/09/2013 |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, consumer health care and confectionery products | Health Technology |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidad Complutense de Madrid
 Universidad Complutense de Madrid Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flexus Biosciences, Inc.
Flexus Biosciences, Inc. BiotechnologyHealth Technology Provides cancer therapeutics through innovative apps | Health Technology |
Rapt Therapeutics, Inc.
 Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company that develops microbial genomes into novel therapeutics for oncology and infectious diseases | Health Technology |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
R2M Pharma, Inc.
R2M Pharma, Inc. BiotechnologyHealth Technology Develops, discovers and manufactures pharmaceutical products | Health Technology |
Bella Charitable Foundation
Bella Charitable Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a grant making charity | Miscellaneous |
Breakpoint Therapeutics GmbH
Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops anti-cancer and oncology drugs | Health Technology |
Shasqi, Inc.
Shasqi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
MarketScreener is also available in this country: United States.
Switch edition
